| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Sulforaphane | Dyslipidemia | 2 | PM | 33833347 | 📋 | Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis |
| Sulforaphane | Dyslipidemia | 1 | PM | 30597379 | 📋 | Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats |
| Sulforaphane | HDL Low | 1 | PM | 20688330 | 📋 | Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells |
| Sulforaphane | Hyperuricemia | 1 | PM | 36371056 | 📋 | Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia |
| Sulforaphane | LDL / HDL Ratio | 1 | PM | 20688330 | 📋 | Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells |
| Sulforaphane | Platelet Aggregation | 1 | PM | 29797311 | 📋 | The isothiocyanate sulforaphane modulates platelet function and protects against cerebral thrombotic dysfunction |
